Paula O’Connor

Paula O’Connor

Company: Nurix Therapeutics

Job title: Chief Medical Officer

Seminars:

Clinical Activity of NX-5948 in CLL & NHL: A First-in-Class BTK Degrader 9:00 am

Emerging clinical data support utility of novel MOA against validated target Activity demonstrated in the CNS and in patients harboring BTKi resistance mutationsRead more

day: Day Two AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.